AstraZeneca, a biopharmaceutical company, has completed the purchase of a US-based biotechnology company, Ardea Biosciences. Upon completion of the merger, approved by Ardea's stockholders, each outstanding share of Ardea common stock has ...
Tags: purchase, AstraZeneca, Ardea Biosciences, biopharmaceutical
Astellas Pharma and Medivation have announced the submission of marketing authorization application (MAA) to the European Medicines Agency (EMA) for enzalutamide to treat metastatic castration-resistant prostate cancer in men who have ...
Tags: enzalutamide, metastatic castration-resistant prostate cancer
The US Food and Drug Administration (FDA) has approved Pfizer's Lyrica (pregabalin) capsules CV for the management of neuropathic pain associated with spinal cord injury based on priority review. The FDA approval is based on two ...
Tags: FDA approval, neuropathic pain, Lyrica, clinical researh
Janssen Research & Development has announced that it has submitted a supplemental New Drug Application to FDA for ZYTIGA(abiraterone acetate). Janssen-Cilag International NV has also sent a type II variation to the European Medicines ...
Teva UK, a generic pharmaceutical company, has introduced (Oroeze) Benzydamine 0.15% w/v Oromucosal spray. The (Oroeze) Benzydamine 0.15% w/v Oromucosal spray is available in the Teva 360 livery. The new product is a version of Difflam ...
Tags: Medicine, Benzydamine 0.15%w/v Oromucosal spray, Difflam
The Committee for Orphan Medicinal Products (COMP) of the European Medicines Agency (EMA) has recommended Orphan Drug Designation (ODD) for Erytech Pharma's investigational product Enhoxy. The drug, which is used to treat sickle cell ...
Tags: orphan drug designation, Erytech product, debilitating disease
Raptor Pharmaceutical has announced FDA acceptance of new drug application (NDA) for Cysteamine Bitartrate delayed-release capsules (RP103) for the potential treatment of nephropathic cystinosis. RP103 gained standard review designation ...
Tags: nephropathic cystinosis, FDA acceptance, NDA submission
In May, the total retail sales of consumer goods reached 1,671.5 billion yuan, up by 13.8 percent year-on-year (Nominal growth rate. The real growth rate was 11.0 percent. The follows are nominal growth rates if there's no additional ...
Tags: retail sales, consumer goods, up, month-on-month
The US Food and Drug Administration (FDA) has approved Genentech's Perjeta (pertuzumab) for the treatment of HER2-positive metastatic breast cancer (mBC), in combination with Herceptin (trastuzumab) and docetaxel chemotherapy. The ...
Tags: FDA approval, breast cancer, clinical study, pharmaceutical product
In May, the consumer price index (CPI) went up by 3.0 percent year-on-year. The prices grew by 3.0 percent in cities and 2.9 percent in rural areas. The food prices went up by 6.4 percent, while the non-food prices increased by 1.4 ...
Tags: Consumer Prices, China, economy development, financial report
Eli Lilly and Company has officially opened the Lilly China Research and Development Center (LCRDC), a diabetes-focused research and development center in Shanghai, China. The focus of LCRDC is on the discovery of new diabetes medicines ...
Tags: Eli Lilly and Company, China Research and Development Center, diabetes
The European Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for Vertex Pharmaceuticals' Kalydeco (ivacaftor) to treat the underlying cause of cystic fibrosis (CF). Kalydeco is indicated for people ...
Tags: Kalydeco, cystic fibrosis, clinical study
In April, the total retail sales of consumer goods reached 1,560.3 billion yuan, up by 14.1 percent year-on-year (Nominal growth rate. The real growth rate was 10.7 percent. The follows are nominal growth rates if there's no additional ...
Tags: total retail sales, consumer goods, industrial enterprises
In April, the consumer price index (CPI) went up by 3.4 percent year-on-year. The prices grew by 3.4 percent in cities and 3.3 percent in rural areas. The food prices went up by 7.0 percent, while the non-food prices increased by 1.7 ...
Tags: CPI, consumer price index, food prices, consumer prices
BOTOX Cosmetic (onabotulinumtoxinA) Celebrates 10-Year Anniversary of U.S. Food and Drug Administration Approval. BOTOX Cosmetic is a prescription medicine that is injected into muscles and used to improve the look of moderate to severe ...
Tags: BOTOX Cosmetic, 10-year anniversary, FDA, frown lines, glabellar lines